APA (7th ed.) Citation

P, V., P, T., AM, W., SJ, W., R, B., S, C., . . . G, H. (2025). A phase I/IIa trial of PXS-5505, a novel pan-lysyl oxidase inhibitor, in advanced myelofibrosis. Haematologica, 110(10), 2376. https://doi.org/10.3324/haematol.2024.287231

Chicago Style (17th ed.) Citation

P, Vachhani, et al. "A Phase I/IIa Trial of PXS-5505, a Novel Pan-lysyl Oxidase Inhibitor, in Advanced Myelofibrosis." Haematologica 110, no. 10 (2025): 2376. https://doi.org/10.3324/haematol.2024.287231.

MLA (9th ed.) Citation

P, Vachhani, et al. "A Phase I/IIa Trial of PXS-5505, a Novel Pan-lysyl Oxidase Inhibitor, in Advanced Myelofibrosis." Haematologica, vol. 110, no. 10, 2025, p. 2376, https://doi.org/10.3324/haematol.2024.287231.